DPDiana Pop-Lodromanean

Diana Pop-Lodromanean

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Diana Pop-Lodromanean has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Disentangling Procedural and Patient-Specific Drivers of Perioperative Outcomes in Pelvic Organ Prolapse Surgery: A Stratified Multigroup Analysis

    by Diana Pop-Lodromanean, Nicolae Grigore, Adrian Hasegan, Samuel Bogdan Todor, Paula Anderco, Radu Chicea, Cristian Ichim, Livia-Mirela Popa

    Background: Perioperative outcomes in pelvic organ prolapse (POP) surgery remain difficult to predict due to substantial heterogeneity in both surgical techniques and patient characteristics. Existing studies typically evaluate these factors in isolation, limiting their ability to support individualized risk stratification. This study introduces a stratified analytical framework to disentangle the relative impact of procedural and patient-related determinants across common vaginal reconstructive approaches. Methods: A retrospective cohort of 376 women undergoing POP surgery between 2020 and 2025 was analyzed. Patients were stratified into three procedure groups: sacrospinous fixation with mid-urethral sling (SFM + TOT/TVT), anterior and posterior repair with sling (A&P + TOT/TVT), and isolated anterior and posterior repair (A&P alone). Key outcomes included intraoperative blood loss, length of hospitalization, postoperative hospital stay and catheterization time. Within-group predictors were assessed using stratified odds ratios and synthesized via a random-effects model. Results: Procedure type was consistently associated with recovery-related outcomes, although it explained only a modest proportion of outcome variability. Patients undergoing A&P repair exhibited significantly prolonged hospitalization (8.00 vs. 6.29 and 6.94 days), postoperative recovery (4.99 vs. 3.48 and 4.17 days), and catheterization duration (3.31 vs. 2.33 and 2.86 days) (all p < 0.001). In contrast, intraoperative blood loss was primarily driven by patient-specific factors, including concomitant hysterectomy, prolapse severity, obesity, age, and obstetric history. Prolonged hospitalization was strongly associated with combined procedural complexity and clinical burden, while catheterization duration was influenced by postoperative complications and parity. Conclusions: This study demonstrates that perioperative outcomes in POP surgery arise from distinct and interacting domains: procedural factors predominantly shape recovery trajectories, whereas patient characteristics govern intraoperative risk. The proposed stratified random-effects framework enables integrated evaluation across heterogeneous surgical groups and provides an exploratory basis for identifying domains that may inform future individualized perioperative risk models.

  • Open Access

    From Mesh to Modern Therapies: An Updated Narrative Review on Urogenital Prolapse

    by Diana Pop-Lodromanean, Radu Chicea, Dan-Georgian Bratu, Livia-Mirela Popa, Paula Anderco, Nicolae Grigore, Adrian Hașegan

    Urogenital prolapse (UP), a manifestation of pelvic organ prolapse (POP), is prevalent and burdensome, impairing urinary, bowel, sexual and psychosocial health. This review synthesizes evidence on epidemiology, mechanisms, clinical evaluation and treatment, with an emphasis on mesh use. POP results from failure of muscular and fascial support, most consistently associated with childbirth and aging; imaging links levator ani avulsion and hiatal overstretching to onset and recurrence. Diagnosis is chiefly clinical, using standardized pelvic examination, with selective adjuncts such as urodynamics, cystoscopy, pelvic floor ultrasound and defecography. Conservative care includes education, lifestyle measures, pelvic floor muscle training and pessaries. Surgery is considered for bothersome prolapse and individualized by compartment, symptoms, sexual goals, comorbidities and preference. Options span native-tissue vaginal repairs with apical suspension, obliterative procedures for non-sexually active patients and sacrocolpopexy. Sacrocolpopexy remains the durability benchmark for apical support but carries mesh-related risks that accumulate over time. Regulatory scrutiny followed rising complications, culminating in withdrawal of transvaginal mesh kits for anterior prolapse, while mesh for sacrocolpopexy persists. Quality-of-life outcomes are central to assessment. Pain after mesh may reflect placement or evolution (erosion, proximity) or persist despite normal findings, implicating neuroplastic mechanisms. Individualized, shared decision-making is essential to balance durability, safety and function.


  • Open Access

    MicroRNAs in the Diagnosis of Digestive Diseases: A Comprehensive Review

    by Mirela Livia Popa, Cristian Ichim, Paula Anderco, Samuel Bogdan Todor, Diana Pop-Lodromanean

    MicroRNAs (miRNAs) have emerged as crucial regulators in digestive pathologies, including inflammatory bowel disease (miR-31, miR-155, and miR-21), colorectal cancer (miR-21, miR-598, and miR-494), and non-alcoholic fatty liver disease (miR-21, miR-192, and miR-122). Their capacity to modulate gene expression at the post-transcriptional level makes them highly promising candidates for biomarkers and therapeutic interventions. However, despite considerable progress, their clinical application remains challenging. Research has shown that miRNA expression is highly dynamic, varying across patients, disease stages, and different intestinal regions. Their dual function as both oncogenes and tumor suppressors further complicates their therapeutic use, as targeting miRNAs may yield unpredictable effects. Additionally, while miRNA-based therapies hold great potential, significant hurdles persist, including off-target effects, immune activation, and inefficiencies in delivery methods. The intricate interplay between miRNAs and gut microbiota adds another layer of complexity, influencing disease mechanisms and treatment responses. This review examined the role of miRNAs in digestive pathologies, emphasizing their diagnostic and therapeutic potential. While they offer new avenues for disease management, unresolved challenges underscore the need for further research to refine their clinical application.